Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Patients with Hematologic Malignancies Who Relapse following Autologous Transplantation: A Multi-Institutional Prospective Study from the Cancer and Leukemia Group B (CALGB trial 100002) Bashey, Asad , Owzar, Kouros , Johnson, Jeffrey L. ... - - Biol. Blood Marrow Transplant. - 2011 Manuscript - Primary - Primary - Transplant - CALGB-100002
Updated analysis of CALGB 100104 (Alliance): a randomised phase III study evaluating lenalidomide vs placebo maintenance after single autologous stem cell transplant for multiple myeloma Holstein, Sarah A. , Jung, Sin-Ho , Richardson, Paul G. ... - - Lancet Haematol - 2017 Manuscript - Primary - Long-Term-Followup - Myeloma - CALGB-100104
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma McCarthy, Philip L. , Owzar, Kouros , Hofmeister, Craig C. ... - - N. Engl. J. Med. - 2012 Manuscript - Primary - Primary - Myeloma - CALGB-100104
Reduced Intensity Allogeneic Transplantation Provides High Event-Free And Overall Survival In Patients With Advanced Indolent B Cell Malignancies: CALGB 109901 Shea, Thomas , Johnson, Jeffrey , Westervelt, Peter , Farag, Sherif ... - - Biol Blood Marrow Transplant - 2011 Manuscript - Primary - Primary - Transplant - CALGB-109901
